Key facts
- It has raised $150K; the latest was Seed Round ($150K) in Dec 2025.
- Notable investors include Right Side Capital Management.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Previze.AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Previze.AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Previze.AI
Developer of AI-powered predictive healthcare software designed for oncology providers managing bone metastases in cancer patients. The company offers fracture risk prediction tools, vertebral compression fracture analytics, clinical decision support systems, patient risk stratification models, imaging-based AI assessments, and preventive care guidance technology, enabling earlier intervention and improved patient outcomes.
- Sector
- Healthcare
- HQ
- Houston, TX, United States
- Founded
- 2025
- Employees
- 2
- Website
- previzeai.com/
- Ownership
- Privately Held (backing)
Previze.AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Previze.AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Previze.AI in its N-PORT filings yet. We sweep new filings monthly.